Malignant lymphoepithelial lesions of the salivary gland. 2006

Yao-Chung Hsu, and Hsiao-Feng Lu, and Chao-Cheng Huang, and Ruey-Fen Hsu, and Chih-Ying Su
Department of Otolaryngology, Chang Gung Memorial Hospital, Kaohsiung, Taiwan.

OBJECTIVE To describe a relatively large series of patients with uncommon malignant lymphoepithelial lesions (MLEL) in the salivary glands, to present treatment-outcome data to support therapeutic decision-making, and to evaluate the incidence of co-occurrence of MLEL and Epstein-Barr virus (EBV). METHODS Ten patients with MLEL were treated between 1987 and 2002. All lesions were surgically removed, with or without neck dissection, and the patients treated with radiotherapy or radiotherapy and chemotherapy. Histopathology and in situ hybridization studies for EBV-encoded RNA (EBER1) were performed. RESULTS With aggressive treatment, outcomes were good, regardless of the presenting stage, except when distal metastases were present. All 10 patients tested positive for EBV. CONCLUSIONS This and previous investigations support the use of aggressive surgical excision of the tumor and local metastases and radiotherapy or radiotherapy and chemotherapy, as optimal treatment for MLEL. The EBV finding may indicate a role for EBV in the pathogenesis of MLEL. METHODS C-4.

UI MeSH Term Description Entries
D008204 Lymphangiosarcoma A malignant tumor originating from the endothelial cells of lymphatic vessels. Most lymphangiosarcomas arise in an arm secondary to radical mastectomy but they sometimes complicate idiopathic lymphedema. The lymphedema has usually been present for 6 to 10 years before malignant changes develop. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1866) Lymphangioendothelioma, Malignant,Lymphangioendotheliomas, Malignant,Lymphangiosarcomas,Malignant Lymphangioendothelioma,Malignant Lymphangioendotheliomas
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Yao-Chung Hsu, and Hsiao-Feng Lu, and Chao-Cheng Huang, and Ruey-Fen Hsu, and Chih-Ying Su
April 1991, Arctic medical research,
Yao-Chung Hsu, and Hsiao-Feng Lu, and Chao-Cheng Huang, and Ruey-Fen Hsu, and Chih-Ying Su
September 1986, Human pathology,
Yao-Chung Hsu, and Hsiao-Feng Lu, and Chao-Cheng Huang, and Ruey-Fen Hsu, and Chih-Ying Su
January 1986, Revue de laryngologie - otologie - rhinologie,
Yao-Chung Hsu, and Hsiao-Feng Lu, and Chao-Cheng Huang, and Ruey-Fen Hsu, and Chih-Ying Su
September 1984, American journal of clinical pathology,
Yao-Chung Hsu, and Hsiao-Feng Lu, and Chao-Cheng Huang, and Ruey-Fen Hsu, and Chih-Ying Su
November 2012, Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery,
Yao-Chung Hsu, and Hsiao-Feng Lu, and Chao-Cheng Huang, and Ruey-Fen Hsu, and Chih-Ying Su
October 1991, American journal of surgery,
Yao-Chung Hsu, and Hsiao-Feng Lu, and Chao-Cheng Huang, and Ruey-Fen Hsu, and Chih-Ying Su
May 2007, Ear, nose, & throat journal,
Yao-Chung Hsu, and Hsiao-Feng Lu, and Chao-Cheng Huang, and Ruey-Fen Hsu, and Chih-Ying Su
January 1984, Archives of otolaryngology (Chicago, Ill. : 1960),
Yao-Chung Hsu, and Hsiao-Feng Lu, and Chao-Cheng Huang, and Ruey-Fen Hsu, and Chih-Ying Su
June 1997, Archives of otolaryngology--head & neck surgery,
Yao-Chung Hsu, and Hsiao-Feng Lu, and Chao-Cheng Huang, and Ruey-Fen Hsu, and Chih-Ying Su
January 1975, Archives of otolaryngology (Chicago, Ill. : 1960),
Copied contents to your clipboard!